Premium
Percutaneous suture‐mediated closure of femoral access sites deployed through the procedure sheath: Initial clinical experience with a novel vascular closure device
Author(s) -
Eggebrecht Holger,
Naber Christoph,
Woertgen Uta,
Ringe Sonia,
Konorza Thomas F.M.,
Schmermund Axel,
von Birgelen Clemens,
Haude Michael,
Kroeger Knut,
Erbel Raimund,
Baumgart Dietrich
Publication year - 2003
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10472
Subject(s) - medicine , vascular closure device , percutaneous , hemostasis , surgery , femoral vein , femoral artery , fibrous joint , cardiac catheterization , complication , closure (psychology) , market economy , economics
The objective of this study was to assess the initial safety and feasibility of a novel suture‐mediated device for closure of femoral access sites immediately after diagnostic or interventional cardiac catheterization. In a prospective study, 150 patients (mean age, 61.5 years; 109 male) underwent femoral access closure with a novel suture closure device (Superstitch, Sutura) immediately after diagnostic (n = 106) or interventional (n = 44) catheterization procedures, independently of the coagulation status. All patients were monitored for 24 hr after the procedure. The closure device was successfully deployed in 92% of patients. Immediate hemostasis was achieved in 77% of patients with no differences between patients undergoing diagnostic catheterization or coronary interventions (79% vs. 73%; P = 0.659). After 2 min of additional light manual compression, hemostasis was achieved in 92% of patients. There was one major complication requiring vascular surgery (0.7%). The novel suture closure device is a safe and effective device that allows for immediate closure of femoral puncture sites after both diagnostic and interventional procedures with a low rate of major complications. Cathet Cardiovasc Intervent 2003;58:313‐321. © 2003 Wiley‐Liss, Inc.